Composition comprising cannabinoids for relief of pain
The present technology generally relates to compositions comprising cannabinoids for relieving pain in a subject and to methods of using such compositions for relieving pain in a subject.
1. A composition for topical application comprising:
at least one purified cannabinoid, wherein the purified cannabinoid is cannabidiol (CBD);
at least one anti-inflammatory agent in an amount ranging from between about 10 wt % and about 90 wt % of the total weight of the composition, wherein the anti-inflammatory agent is methyl salicylate; and
at least one botanical extract, wherein the botanical extract is arnica.
2. The composition of claim 1 , further comprising a terpene or terpenoid.
3. The composition of claim 2 , wherein the terpene or terpenoid is menthol, camphor, or a combination thereof.
4. The composition of claim 2 , wherein the terpene is an isolate, an extract or a distillate.
5. The composition of claim 1 , further comprising a flavonoid, wherein the flavonoid is an isolate, an extract or a distillate.
6. The composition of claim 1 , wherein the purified cannabinoid is present in an amount ranging from between about 0.5 wt % and about 10 wt % of the total weight of the composition.
7. The composition of claim 1 , wherein the purified cannabinoid is present in an amount ranging from between about 2 wt % and about 8 wt % of the total weight of the composition.
8. The composition of claim 1 , wherein the purified cannabinoid is present in an amount ranging from between about 2 wt % and about 6 wt % of the total weight of the composition.
9. The composition of claim 1 , wherein the anti-inflammatory agent is present in an amount ranging from between about 10 wt % and about 25 wt % of the total weight of the composition.
10. The composition of claim 1 , wherein the anti-inflammatory agent is present in an amount ranging from between about 20 wt % and about 90 wt % of the total weight of the composition.
11. The composition of claim 1 , wherein the anti-inflammatory agent is present in an amount of, about 10 wt %, about 15 wt %, about 20 wt % or about 25 wt % of the total weight of the composition.
12. The composition of claim 1 , wherein the botanical extract is present in an amount ranging from between about 0.5 wt % and about 90 wt % of the total weight of the composition.
13. The composition of claim 1 , wherein the botanical extract is present in an amount ranging from between about 1 wt % and about 25 wt % of the total weight of the composition.
14. The composition of claim 1 , wherein the botanical extract is present in an amount ranging from between about 0.5 wt % and about 10 wt % of the total weight of the composition.
15. A composition for topical application comprising:
at least one purified cannabinoid in an amount of between about 0.5 wt % and about 10 wt % of the total weight of the composition, wherein the purified cannabinoid is cannabidiol (CBD);
at least one anti-inflammatory agent in an amount of and about 10 wt % of the total weight of the composition, wherein the anti-inflammatory agent is methyl salicylate; and
at least one botanical extract in an amount of between about 1 wt % and about 25 wt % of the total weight of the composition, wherein the botanical extract is arnica.
16. A composition for topical application comprising:
at least one purified cannabinoid, wherein the purified cannabinoid is cannabidiol (CBD);
at least one anti-inflammatory agent in an amount of between about 10 wt % and about 90 wt % of the total weight of the composition, wherein the anti-inflammatory agent is methyl salicylate;
at least one botanical extract in an amount of between about 0.5 wt % and about 90 wt % of the total weight of the composition, wherein the botanical extract is arnica , and
a terpene or terpenoid, wherein the terpene or terpenoid is menthol, camphor, or a combination thereof.
17. A method for relieving pain in a subject, the method comprising administering to the subject the composition as defined in claim 1 .